Relief of difficult cases of resp, ocular & dermatologic allergies, as well as ocular inflammatory disorders where adjunctive systemic corticosteroid therapy is indicated.
Do not take if patient has breathing problem eg, emphysema or chronic bronchitis, glaucoma, difficulty in urination due to enlargement of the prostate gland. Kaposi's sarcoma. Patients w/ CHF, HTN or renal insufficiency. Drug-induced secondary adrenocortical insufficiency. Avoid use w/ alcohol, sedatives & tranquilizers. May affect ability to drive or operate machinery. Pregnancy & lactation.
Betamethasone: Reduced effects w/ phenobarb, phenytoin, rifampicin or ephedrine. Excessive corticosteroid effects w/ estrogen. May enhance hypokalemia w/ K-depleting diuretics & arrhythmias or digitalis toxicity w/ cardiac glycosides. May enhance K depletion caused by amphotericin B. May increase or decrease anticoagulant effects w/ coumarin-type anticoagulants. May increase occurrence or severity of GI ulceration w/ NSAIDs or alcohol. Dexchlorpheniramine maleate: Prolonged or intensified effect w/ MAOIs. May potentiate sedative effect w/ alcohol, TCAs, barbiturates or other CNS depressants. May inhibit action of oral anticoagulants.
Sign Out
